id: NEW:hyperglycemia_to_NEW:covid_19_mortality
name: Hyperglycemia (High Blood Glucose) â†’ COVID-19 Mortality
from_node:
  node_id: NEW:hyperglycemia
  node_name: Hyperglycemia (High Blood Glucose)
to_node:
  node_id: NEW:covid_19_mortality
  node_name: COVID-19 Mortality
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Hyperglycemia (elevated blood glucose levels) creates a pro-inflammatory
  state and impairs immune function, reducing the body''s ability to mount an effective
  response against SARS-CoV-2 infection'
- 'Step 2: High blood glucose promotes viral replication and glycosylation of ACE2
  receptors, potentially enhancing viral entry and cellular damage in respiratory
  and other organ systems'
- 'Step 3: Hyperglycemia contributes to endothelial dysfunction and a hypercoagulable
  state, increasing risk of acute respiratory distress syndrome (ARDS), acute cardiac
  injury, and acute kidney injury'
- 'Step 4: These complications lead to progression from non-critical to critical COVID-19,
  increased need for ICU admission and mechanical ventilation, and ultimately higher
  mortality rates'
evidence:
  quality_rating: A
  n_studies: 8
  primary_citation: 'M. Lee et al. 2020. Effects of hyperglycaemia on complications
    of COVID-19: A meta-analysis of observational studies. Diabetes, obesity and metabolism.'
  supporting_citations: []
description: Meta-analysis of 8 observational studies (n=2729) found that hyperglycemic
  COVID-19 patients, regardless of diabetes status, had significantly higher mortality
  (17% vs normoglycemic patients), greater ICU admission rates (11%), higher need
  for ventilation (23%), and increased risk of severe complications including ARDS
  (15%), acute cardiac injury (14%), and acute kidney injury (5%). The association
  persisted in both diabetic and non-diabetic populations, emphasizing that elevated
  blood glucose itself is a critical prognostic factor.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 0.17
    type: proportion
    ci_lower: 0.1
    ci_upper: 0.25
  p_value: null
  sample_size: 2729
moderators:
- name: diabetes_status
  direction: strengthens
  strength: moderate
  description: Diabetic patients with hyperglycemia showed 16% mortality rate compared
    to 5% in non-diabetic hyperglycemic patients, though both groups had elevated
    risk compared to normoglycemic patients
- name: glycemic_control
  direction: weakens
  strength: strong
  description: Diabetic COVID-19 patients with controlled blood glucose had significantly
    better outcomes than those with hyperglycemia, suggesting glycemic control as
    a modifiable risk factor
